Current funding opportunities related to TB and HIV, expired RFAs will be hidden after closing date. Sort using the tags menu to the right.
For funding opportunities related to global health, please see the Vanderbilt Institute for Global Health announcements found here.
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed), expires: 07/29/2023
Application Due Date(s): July 28, 2021; July 28, 2022; July 28, 2023, by 5:00 PM local time of applicant organization.
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these institutions with advanced training in the management of NIH grants. The ultimate goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and Federal research funding requirements for NIAID-supported foreign institutions in low to middle-income countries.
https://grants.nih.gov/grants/guide/pa-files/PAR-21-037.html
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 and R21), expires: 01/14/2022
R01 Application Due Date(s): January 14, 2020, January 14, 2021, and January 14, 2022 by 5:00 PM local time of applicant organization.
R21 Application Due Date(s): January 14, 2020; January 14, 2021, by 5:00 PM local time of applicant organization
This Funding Opportunity Announcement (FOA) encourages innovative, high risk, high impact research to investigate the innate and/or adaptive immune responses induced by mycobacterial infections, Bacillus Calmette-Guérin vaccine (BCG) and/or candidate Mycobacterium tuberculosis (Mtb) vaccines in HIV-infected or uninfected individuals. Studies that will provide insights into the immune mechanisms required for protection from Mtb infection/re-infection or progression to active disease in latently infected individuals are encouraged. This research is expected to provide data to advance new hypotheses on immune mechanisms that contribute to the advancement of new tuberculosis (TB) vaccines, including in populations also infected with HIV.
R01: https://grants.nih.gov/grants/guide/pa-files/PAR-19-307.html
R21: https://grants.nih.gov/grants/guide/pa-files/PAR-18-923.html
Research on the Health of Transgender and Gender Nonconforming Populations (R01/R21), expires 01/08/2021
Application Due Dates: Standard dates/ AIDS dates apply, by 5:00 PM local time of applicant organization.
This funding opportunity announcement (FOA) calls for research on the health of transgender and gender nonconforming people of all ages, including both youth and adults who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.
R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-729.html
R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-728.html